Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
85,232,624
-
Shares change
-
+21,242,435
-
Total reported value, excl. options
-
$1,021,045,667
-
Value change
-
+$262,239,455
-
Put/Call ratio
-
27%
-
Number of buys
-
97
-
Number of sells
-
-46
-
Price
-
$11.98
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2022
190 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q3 2022.
Gossamer Bio, Inc. - Common Stock (GOSS) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85,232,624 shares
of 227,306,614 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7,420,974 shares), VANGUARD GROUP INC (7,346,163 shares), BlackRock Inc. (5,508,177 shares), EcoR1 Capital, LLC (4,160,887 shares), STATE STREET CORP (3,777,903 shares), BOXER CAPITAL, LLC (3,571,928 shares), NEA Management Company, LLC (3,467,406 shares), Artal Group S.A. (3,246,624 shares), Cormorant Asset Management, LP (3,198,382 shares), and Weiss Asset Management LP (2,773,924 shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.